Tenaya Therapeutics Inc.
TNYA | NASDAQ
$0.68
+$0.01 (+0.92%)
Sep 22, 2026, 12:06 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.21 | -1.09 | -1.93 | -0.73 | -11.21 | -16.51 |
PEG Ratio | 0.02 | 0.05 | 0.05 | -0.01 | -0.14 | 7.84 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.88 | 1.31 | 1.71 | 0.37 | 2.81 | 4.53 |
P/FCF Ratio | -1.58 | -1.33 | -2.31 | -0.72 | -9.11 | -13.96 |
P/OCF Ratio | -1.59 | -1.34 | -2.34 | -0.86 | -12.87 | -17.81 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.09 | 0.15 | 0.09 | 0.06 | 0.06 | n/a |
Quick Ratio | 6.84 | 4.22 | 4.91 | 7.99 | 11.73 | 25.78 |
Current Ratio | 6.84 | 4.22 | 4.91 | 7.99 | 11.73 | 25.78 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -73.50% | -119.68% | -89% | -50.81% | -26.11% | -27.54% |
Return on Assets | -61.66% | -92.65% | -72.77% | -44.33% | -22.97% | -25.91% |
Return on Invested Capital | -69.39% | -108.62% | -86.25% | -48.56% | -24.52% | -27.19% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove TNYA